Kazuki Nomura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kazuki Nomura has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Takumi Mitsuhashi
Department of Neurosurgery, Juntendo University, Tokyo, 1138421, Japan; Epilepsy Center, Juntendo University Hospital, Tokyo, 1130033, Japan
6 shared publications Tetsuya Ueda
Department of Neurosurgery, Juntendo University, Tokyo, 1138421, Japan; Epilepsy Center, Juntendo University Hospital, Tokyo, 1130033, Japan
5 shared publicationsHidenori Sugano
Department of Neurosurgery, Juntendo University, Tokyo, 1138421, Japan; Epilepsy Center, Juntendo University Hospital, Tokyo, 1130033, Japan; Sugano Neurosurgery Clinic, Tokyo, 1350062, Japan
4 shared publications- Hiroharu Suzuki
Department of Neurosurgery, Juntendo University, Tokyo, 1138421, Japan; Epilepsy Center, Juntendo University Hospital, Tokyo, 1130033, Japan
4 shared publications Madoka Nakajima
Department of Neurosurgery, Juntendo University, Tokyo, 1138421, Japan; Epilepsy Center, Juntendo University Hospital, Tokyo, 1130033, Japan
4 shared publicationsAkihide Kondo
3 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216, 125426
MRI-Only Preoperative Localization and Semiautomated Three-Dimensional Modeling of the Cervical Vagus Nerve for Vagus Nerve Stimulation Implantation
- 15 October 2026
- Published by Elsevier in World Neurosurgery
- Vol. 216, 125426
Open AccessMRI-Only Preoperative Localization and Semiautomated Three-Dimensional Modeling of the Cervical Vagus Nerve for Vagus Nerve Stimulation Implantation
- Open Access
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
Low-dose initiation and slow titration of fenfluramine in Lennox–Gastaut syndrome: a retention-oriented real-world study
ObjectiveFenfluramine (FFA) is effective for Lennox–Gastaut syndrome (LGS); however, practical strategies for introducing FFA while maintaining treatment tolerability and long-term retention remain unclear. We conducted a single-center real-world study using a low-dose initiation and slow titration protocol.MethodsThis retrospective study included consecutive patients with LGS treated with FFA at a tertiary epilepsy center following its approval in Japan. FFA was initiated at 0.05 mg/kg/day in all patients and titrated at intervals of 30–60 days. Treatment retention, adverse events (AEs), tonic seizure frequency, and patient-centered functional changes were assessed.ResultsThirteen patients were included. Treatment was continued in 12 of 13 patients (92%). AEs occurred in 7 of 13 patients (54%), including appetite loss or weight reduction (6 patients) and somnolence or decreased activity (4 patients); these events were manageable with dose adjustment. Tonic seizures decreased in 12 of 13 patients, and ≥50% reduction was achieved in 8 of 13 patients based on seizure days per month. Seizure reduction prior to reaching 0.2 mg/kg/day was observed in 7 of 13 patients. Functional improvement, including enhanced alertness, activity, or social interaction, was documented in 5 of 13 patients (38%).ConclusionLow-dose initiation (0.05 mg/kg/day) with slow titration of FFA was associated with high treatment retention, clinically meaningful tonic seizure reduction, and observable functional improvements in patients with highly refractory LGS. These findings support the feasibility of a retention-oriented dosing strategy when introducing FFA in routine clinical practice.
- 24 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessLow-dose initiation and slow titration of fenfluramine in Lennox–Gastaut syndrome: a retention-oriented real-world study
ObjectiveFenfluramine (FFA) is effective for Lennox–Gastaut syndrome (LGS); however, practical strategies for introducing FFA while maintaining treatment tolerability and long-term retention remain unclear. We conducted a single-center real-world study using a low-dose initiation and slow titration protocol.MethodsThis retrospective study included consecutive patients with LGS treated with FFA at a tertiary epilepsy center following its approval in Japan. FFA was initiated at 0.05 mg/kg/day in all patients and titrated at intervals of 30–60 days. Treatment retention, adverse events (AEs), tonic seizure frequency, and patient-centered functional changes were assessed.ResultsThirteen patients were included. Treatment was continued in 12 of 13 patients (92%). AEs occurred in 7 of 13 patients (54%), including appetite loss or weight reduction (6 patients) and somnolence or decreased activity (4 patients); these events were manageable with dose adjustment. Tonic seizures decreased in 12 of 13 patients, and ≥50% reduction was achieved in 8 of 13 patients based on seizure days per month. Seizure reduction prior to reaching 0.2 mg/kg/day was observed in 7 of 13 patients. Functional improvement, including enhanced alertness, activity, or social interaction, was documented in 5 of 13 patients (38%).ConclusionLow-dose initiation (0.05 mg/kg/day) with slow titration of FFA was associated with high treatment retention, clinically meaningful tonic seizure reduction, and observable functional improvements in patients with highly refractory LGS. These findings support the feasibility of a retention-oriented dosing strategy when introducing FFA in routine clinical practice.
- 19 May 2026
- Published by Elsevier in Clinical Neurophysiology
- Vol. 189, 2111938
Propagation concordance index reflects spatial proximity to the spike generator by linking interictal spikes with stimulation-induced neural propagation
- 19 May 2026
- Published by Elsevier in Clinical Neurophysiology
- Vol. 189, 2111938
Propagation concordance index reflects spatial proximity to the spike generator by linking interictal spikes with stimulation-induced neural propagation
- Open Access
- 10 February 2026
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 11, 126-132
Effective connectivity between homologous cortices mediated by the corpus callosum: An axono-cortical evoked potentials study
- 10 February 2026
- Published by Elsevier in Clinical Neurophysiology Practice
- Vol. 11, 126-132
Open AccessEffective connectivity between homologous cortices mediated by the corpus callosum: An axono-cortical evoked potentials study
- Open Access
- 30 January 2026
- Published by Elsevier in NeuroImage
- Vol. 328, 121768
SEEG dynamic tractography–based spike source localization is useful across diverse brain regions and etiologies
- 30 January 2026
- Published by Elsevier in NeuroImage
- Vol. 328, 121768
Open AccessSEEG dynamic tractography–based spike source localization is useful across diverse brain regions and etiologies
- 8 August 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 131, 327-333
Neurodevelopmental milestone acquisition following early hemispherotomy in Sturge-Weber syndrome
- 8 August 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 131, 327-333
Neurodevelopmental milestone acquisition following early hemispherotomy in Sturge-Weber syndrome